Skip to content
XSNX 0.01 0.00 -9.09%
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Menu
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
XSNX 0.01 0.00 -9.09%
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Menu
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Day:
October 26, 2022
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1